The authors suggested that MEL may modulate neuroinflammation by reducing the activation of the NF-κB cascade and the nuclear erythroid 2-related factor 2 (Nrf2) pathway, which may be responsible, at least in part, for its neuroprotective effect on DN. The gene discussed is NFE2L2; the disease is liver dysplastic nodule.